| Dr Hideki Shikata, MD | |
|
2010 S Arlington Heights Rd, Suite 101, Arlington Heights, IL 60005-4134 | |
| (847) 952-8910 | |
| (847) 952-0606 |
| Full Name | Dr Hideki Shikata |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 30 Years |
| Location | 2010 S Arlington Heights Rd, Arlington Heights, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578590816 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 036-093573 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nihon Medical Clinic, S.c. | 2567623002 | 4 |
News Archive
In the meantime, the budget also proposes $5.5 billion for "risk corridors" in 2015 to pay insurers who find themselves with a higher number of sicker and older people they must insure. Some call that program a bailout.
The study carried out by the Complutense University of Madrid (Spain) –UCM – is the first to evaluate retinal damage using tablets with LED screens available in the market with living animals.
The UK government operates a no tolerance policy to patient violence and antisocial behaviour in emergency departments, but staff are often reluctant to report incidents. This can cause significant disruption to the departments and stress for staff.
Human Genome Sciences, Inc. today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for approval to market BENLYSTA® (belimumab) for the treatment of systemic lupus erythematosus (SLE).
› Verified 1 days ago
| Entity Name | Nihon Medical Clinic, S.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548532526 PECOS PAC ID: 2567623002 Enrollment ID: O20120411000029 |
News Archive
In the meantime, the budget also proposes $5.5 billion for "risk corridors" in 2015 to pay insurers who find themselves with a higher number of sicker and older people they must insure. Some call that program a bailout.
The study carried out by the Complutense University of Madrid (Spain) –UCM – is the first to evaluate retinal damage using tablets with LED screens available in the market with living animals.
The UK government operates a no tolerance policy to patient violence and antisocial behaviour in emergency departments, but staff are often reluctant to report incidents. This can cause significant disruption to the departments and stress for staff.
Human Genome Sciences, Inc. today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for approval to market BENLYSTA® (belimumab) for the treatment of systemic lupus erythematosus (SLE).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hideki Shikata, MD 2010 S Arlington Heights Rd, Suite 101, Arlington Heights, IL 60005-4134 Ph: () - | Dr Hideki Shikata, MD 2010 S Arlington Heights Rd, Suite 101, Arlington Heights, IL 60005-4134 Ph: (847) 952-8910 |
News Archive
In the meantime, the budget also proposes $5.5 billion for "risk corridors" in 2015 to pay insurers who find themselves with a higher number of sicker and older people they must insure. Some call that program a bailout.
The study carried out by the Complutense University of Madrid (Spain) –UCM – is the first to evaluate retinal damage using tablets with LED screens available in the market with living animals.
The UK government operates a no tolerance policy to patient violence and antisocial behaviour in emergency departments, but staff are often reluctant to report incidents. This can cause significant disruption to the departments and stress for staff.
Human Genome Sciences, Inc. today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for approval to market BENLYSTA® (belimumab) for the treatment of systemic lupus erythematosus (SLE).
› Verified 1 days ago
Dr. Sharon Ann Spak-schreiner, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1051 W Rand Rd # 110, Arlington Heights, IL 60004 Phone: 847-618-9292 Fax: 847-618-9294 | |
Chong H. Pak, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 W Central Rd, Arlington Heights, IL 60005 Phone: 847-618-8400 Fax: 847-618-8409 | |
Rosalina Guerrero-guzman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 675 W Central Rd, Suite 101, Arlington Heights, IL 60005 Phone: 847-342-1554 Fax: 847-342-1711 | |
Dr. Luis Fernando Soruco, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2101 S Arlington Heights Rd, 111, Arlington Heights, IL 60005 Phone: 847-228-3200 Fax: 847-228-3740 | |
Thomas F Cozzi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1430 N Arlington Heights Rd, Ste. #112, Arlington Heights, IL 60004 Phone: 847-394-9900 Fax: 847-394-1855 | |
Dr. Daniel Daeyol So, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2101 S Arlington Heights Rd, 111, Arlington Heights, IL 60005 Phone: 847-228-3200 Fax: 847-228-3740 | |
Dr. Paul A Ruzumna, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1632 W Central Rd, Arlington Heights, IL 60005 Phone: 847-618-2500 Fax: 847-253-8474 |